Ascendis Pharma A/S
NASDAQ:ASND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ascendis Pharma A/S
NASDAQ:ASND
|
DK |
|
C
|
CK Power PCL
SET:CKP
|
TH |
Intrinsic Value
The intrinsic value of Ascendis Pharma A/S (ASND) under the Base Case is 224.306 USD per share.
Compared with the current market price of 226.155 USD, the stock appears
Overvalued by 1% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Ascendis Pharma A/S Does
Ascendis Pharma is a biopharmaceutical company that develops and sells medicines for rare endocrine diseases. Its main products are long-acting treatments built with its TransCon technology, which is designed to release medicine slowly so patients do not need frequent dosing. The company sells these drugs to specialty pharmacies, hospitals, doctors, and the payers that cover treatment for patients with chronic hormone disorders.
- Headquarters
- Denmark DK
- Employees
- 1 189
- IPO date
- Jan 28, 2015
Revenue & Expenses Breakdown
Ascendis Pharma A/S
Earnings Waterfall
Ascendis Pharma A/S
The intrinsic value for Ascendis Pharma A/S (ASND) under the Base Case is 224.306 USD.
Compared with the current market price of 226.155 USD, the stock appears Overvalued by 1% .